All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

A 45-year-old man is brought to the emergency department after being rescued from a remote hiking trail. He was lost for two days without access to food or water. On presentation, he is lethargic and confused. Vital signs show a temperature of $37.8^\circ\text{C}$ ( $100.0^\circ\text{F}$ ), pulse of $118/\text{min}$ , blood pressure of $92/58\text{ mmHg}$ , and respiratory rate of $16/\text{min}$ . Physical examination reveals dry mucous membranes, decreased skin turgor, and delayed capillary refill. His estimated premorbid weight is $70\text{ kg}$ .

Initial laboratory evaluation reveals the following:

Test	Result	Reference Range
Serum Sodium	$154\text{ mEq/L}$	$136-145\text{ mEq/L}$
Serum Potassium	$4.1\text{ mEq/L}$	$3.5-5.0\text{ mEq/L}$
Serum Chloride	$118\text{ mEq/L}$	$95-105\text{ mEq/L}$
Serum Bicarbonate	$25\text{ mEq/L}$	$22-28\text{ mEq/L}$
Blood Urea Nitrogen	$50\text{ mg/dL}$	$7-18\text{ mg/dL}$
Serum Creatinine	$1.9\text{ mg/dL}$	$0.6-1.2\text{ mg/dL}$
Serum Glucose	$98\text{ mg/dL}$	$70-110\text{ mg/dL}$

Based on the patient's presentation and laboratory results, what is his estimated free water deficit in liters? (Assume a target normal serum sodium of $140\text{ mEq/L}$ .)

Show answer & explanation

Answer: 4.2

Answer

4.2

The patient is experiencing severe hypovolemic hypernatremia due to unreplaced sensible and insensible free water losses in the setting of environmental exposure. To properly direct intravenous fluid resuscitation (typically with

5\%

dextrose in water or enteral free water), the free water deficit must be calculated. The standard formula is:

\text{Free Water Deficit} = \text{TBW} \times \left( \frac{\text{Measured } Na^+}{\text{Target } Na^+} - 1 \right)

. First, calculate Total Body Water (TBW), which is approximately

60\%

(

0.6

) of lean body weight in a young or middle-aged adult male.

\text{TBW} = 0.6 \times 70\text{ kg} = 42\text{ L}

. Next, insert the measured sodium (

154\text{ mEq/L}

) and the target normal sodium (

140\text{ mEq/L}

) into the formula:

42 \times \left(\frac{154}{140} - 1\right) = 42 \times (1.1 - 1) = 42 \times 0.1 = 4.2\text{ Liters}

Step-by-Step Solution

Determine the patient's estimated Total Body Water (TBW).

For an adult male,

\text{TBW} = 0.6 \times \text{body weight (kg)}

. Therefore,

0.6 \times 70\text{ kg} = 42\text{ L}

Free water deficit calculations rely on the patient's total body water, which varies by sex and age (

0.6

for adult men,

0.5

for adult women and elderly men,

0.45

for elderly women).

Calculate the ratio of measured serum sodium to the target normal serum sodium.

\frac{154\text{ mEq/L}}{140\text{ mEq/L}} = 1.1

This ratio determines the proportional deficit of free water relative to the body's solute concentration.

Apply the free water deficit formula.

\text{Deficit} = \text{TBW} \times (1.1 - 1) = 42 \times 0.1 = 4.2\text{ Liters}

Multiplying the TBW by the excess sodium fraction yields the absolute volume of free water that has been lost.

Key Concept

Calculating free water deficit in hypernatremia

Question 1642Question →

An internal medicine physician is called to the emergency department to evaluate a 61-year-old woman complaining of severe nausea, generalized weakness, and visual changes. She states that over the past 48 hours, she has been seeing "yellowish halos" around lights. Her medical history includes heart failure with reduced ejection fraction, persistent atrial fibrillation, and osteoarthritis. Her chronic daily medications include carvedilol, sacubitril-valsartan, digoxin, and rivaroxaban. Five days ago, she visited an urgent care clinic for purulent nasal discharge and facial pressure, for which she was prescribed a 7-day course of clarithromycin. Since then, she has also been taking over-the-counter naproxen twice daily for sinus headaches and drinking a homemade ginger-root tea to soothe her throat.

Vital signs show a heart rate of 46/min and irregular, blood pressure of 102/65 mmHg, and oxygen saturation of 97% on room air. Physical examination reveals clear lungs bilaterally and no lower extremity edema. Laboratory studies show a serum creatinine of 1.1 mg/dL (baseline 1.0 mg/dL) and a serum potassium of 4.2 mEq/L.

Based on the comprehensive medical history and clinical findings, which of the following historical elements is the primary precipitant of this patient's current syndrome?

Initiation of clarithromycin therapy

Increased frequency of naproxen use

Consumption of ginger-root tea

Long-term sacubitril-valsartan therapy

Progression of underlying heart failure

Show answer & explanation

Answer: Initiation of clarithromycin therapy

Answer

Initiation of clarithromycin therapy

The correct answer identifies the recent addition of a macrolide antibiotic as the catalyst for the patient's symptoms. The triad of gastrointestinal distress, bradycardia, and xanthopsia (yellow-tinted vision/halos) in a patient taking digoxin is pathognomonic for digoxin toxicity. Digoxin is primarily excreted unchanged by the kidneys and is heavily reliant on P-glycoprotein (P-gp) for both intestinal efflux and renal tubular secretion. Clarithromycin is a potent inhibitor of both cytochrome P450 3A4 and P-gp. The inhibition of P-gp significantly increases digoxin bioavailability and decreases its clearance, leading to rapid systemic accumulation and toxicity. Recognizing this requires careful evaluation of the patient's recent medical and pharmacological history.

Step-by-Step Solution

Analyze the clinical presentation.

The patient exhibits severe nausea, profound bradycardia (HR 46/min), and visual changes described as "yellowish halos" (xanthopsia).

Recognizing this classic triad establishes a presumptive diagnosis of acute-on-chronic digoxin toxicity.

Evaluate the medical history for precipitants.

Recent changes include starting clarithromycin, increasing naproxen use, and consuming ginger tea.

Identifying all new historical inputs is essential to pinpoint the trigger for the adverse drug event.

Assess the patient's laboratory values in the context of the history.

Serum creatinine is 1.1 mg/dL, which is very close to her baseline of 1.0 mg/dL. Potassium is normal at 4.2 mEq/L.

This rules out significant acute kidney injury (which could have been caused by naproxen) and hypokalemia as the primary drivers of the digoxin toxicity.

Identify the pharmacokinetic mechanism causing the toxicity.

Clarithromycin is a potent inhibitor of P-glycoprotein (P-gp).

Since digoxin is a substrate for P-gp, its inhibition drastically reduces digoxin's renal and intestinal efflux, causing serum levels to rise to toxic ranges.

Key Concept

Pharmacokinetic evaluation of drug interactions involving P-glycoprotein inhibitors

Estimated Time:1m 30s

Question 1643Question →

A 22-year-old man is evaluated in the cardiology clinic following a syncopal episode that occurred while he was playing a collegiate basketball game. Over the past three months, he has experienced occasional dyspnea on intense exertion. He has no significant past medical history and takes no medications. His family history is notable for the sudden cardiac death of his maternal uncle at age 25. His temperature is 37.0°C (98.6°F), blood pressure is 118/74 mmHg, pulse is 72/min, and respirations are 14/min. Based on the most likely underlying condition, which of the following physical examination findings are expected in this patient? (Select all that apply)

Select all that apply

A harsh crescendo-decrescendo systolic murmur at the left lower sternal border that increases in intensity during the Valsalva maneuver

A rapid, biphasic carotid pulse with two distinct systolic peaks

A delayed and diminished carotid arterial pulse upstroke

A late-peaking systolic murmur that radiates broadly to the carotid arteries

An early diastolic decrescendo murmur best heard at the right upper sternal border

Show answer & explanation

Answer: A harsh crescendo-decrescendo systolic murmur at the left lower sternal border that increases in intensity during the Valsalva maneuver; A rapid, biphasic carotid pulse with two distinct systolic peaks

Answer

A harsh crescendo-decrescendo systolic murmur at the left lower sternal border that increases in intensity during the Valsalva maneuver AND a rapid, biphasic carotid pulse with two distinct systolic peaks.

The correct findings directly reflect the dynamic left ventricular outflow tract (LVOT) obstruction characteristic of hypertrophic cardiomyopathy (HCM). The harsh crescendo-decrescendo systolic murmur of HCM becomes louder with the Valsalva maneuver because decreased venous return leads to a smaller left ventricular cavity, which exacerbates the outflow obstruction. Furthermore, patients with HCM often exhibit a pulsus bisferiens (biphasic carotid pulse) due to a rapid initial ventricular ejection followed by a sudden drop in flow as the outflow tract dynamically narrows mid-systole.

Step-by-Step Solution

Analyze the patient's clinical presentation and demographics.

The patient is a young athlete with exertional syncope, exertional dyspnea, and a family history of sudden premature cardiac death.

Identifying the classic triad of symptoms and family history strongly points toward hypertrophic cardiomyopathy (HCM) as the most likely diagnosis.

Determine the pathophysiological mechanism of the suspected disease.

HCM is characterized by asymmetric septal hypertrophy leading to a dynamic left ventricular outflow tract (LVOT) obstruction.

Understanding the dynamic nature of the obstruction is necessary to predict how the physical examination findings will present and change with physiologic maneuvers.

Correlate the pathophysiology with specific physical examination findings.

The dynamic LVOT obstruction produces a harsh systolic murmur that worsens when left ventricular volume decreases (e.g., during the Valsalva maneuver or standing). Additionally, the rapid initial ejection of blood followed by sudden obstruction creates a biphasic carotid pulse (pulsus bisferiens).

Selecting the findings that specifically match this dynamic physiology rules out other causes of exertional syncope like fixed aortic stenosis.

Key Concept

Hypertrophic cardiomyopathy typically presents with a harsh systolic murmur that increases in intensity with maneuvers that decrease preload (such as the Valsalva maneuver), and a biphasic carotid pulse (pulsus bisferiens).

Question 1644Question →

A 58-year-old man is referred to a hematologist for evaluation of progressive fatigue, easy bruising, and early satiety over the past six months. Physical examination is notable for massive splenomegaly extending 10 cm below the left costal margin; there is no palpable cervical, axillary, or inguinal lymphadenopathy. Laboratory studies show a hemoglobin of $8.2$ g/dL, leukocyte count of $2,100/\mu L$ , and platelet count of $65,000/\mu L$ . A bone marrow aspiration is attempted but yields no fluid (a "dry tap"). The subsequent bone marrow core biopsy demonstrates a hypercellular marrow with extensive infiltration by mononuclear cells possessing abundant, pale cytoplasm and fine, irregular cytoplasmic projections. A reticulin stain of the marrow is markedly positive. Flow cytometry and immunohistochemistry of the biopsy specimen reveal that the neoplastic cells strongly express CD20, CD11c, CD25, and CD103.

Based on the histopathologic and immunophenotypic findings, which of the following is the most likely diagnosis?

Primary myelofibrosis

Splenic marginal zone lymphoma

Hairy cell leukemia

Chronic lymphocytic leukemia

Mantle cell lymphoma

Show answer & explanation

Answer: Hairy cell leukemia

Answer

Hairy cell leukemia

The correct answer is hairy cell leukemia. This patient's presentation of pancytopenia, massive splenomegaly (without prominent lymphadenopathy), and a "dry tap" on aspiration is the classic clinical triad. The diagnosis is definitively established by the bone marrow biopsy, which demonstrates mononuclear cells with fine cytoplasmic projections ("hairy" cells) alongside prominent reticulin fibrosis. Furthermore, the characteristic immunohistochemical profile (positive for CD20, CD11c, CD25, and CD103) confirms the diagnosis and differentiates it from other B-cell neoplasms.

Step-by-Step Solution

Evaluate the clinical presentation and initial laboratory findings.

The patient has pancytopenia, massive splenomegaly without lymphadenopathy, and a "dry tap" on bone marrow aspiration.

This triad strongly suggests a marrow-infiltrative process causing fibrosis and subsequent extramedullary hematopoiesis or splenic pooling.

Analyze the morphological findings on the bone marrow core biopsy.

The biopsy shows an infiltrate of mononuclear cells with abundant, pale cytoplasm and "hair-like" cytoplasmic projections, along with marked reticulin fibrosis.

These cytological features are classic for hairy cells, and the associated fibrosis explains the inability to aspirate marrow.

Correlate the morphology with the immunophenotypic profile.

The neoplastic cells express mature B-cell markers (CD20) alongside highly specific markers including CD11c, CD25, and CD103.

This distinct combination of surface markers definitively confirms the diagnosis of hairy cell leukemia and distinguishes it from other B-cell lymphoproliferative disorders.

Key Concept

Hairy cell leukemia is diagnosed by the combination of a "dry tap" marrow with reticulin fibrosis, characteristic "hairy" mononuclear cells, and a specific CD11c+, CD25+, CD103+ immunophenotype.

Question 1645Question →

A 24-year-old woman is brought to the emergency department by her husband due to a 12-hour history of severe, progressively worsening abdominal pain, nausea, and multiple episodes of nonbilious vomiting. She has not had any fever, diarrhea, or melena. Her medical history is significant for several episodes of sudden-onset, nonpruritic lip and facial swelling over the past five years that typically resolved spontaneously after 2 to 3 days. Her father had a history of similar recurrent episodes of facial swelling. On physical examination, her temperature is 37.1°C (98.8°F), blood pressure is 110/70 mm Hg, pulse is 105/min, and respiratory rate is 16/min. The abdomen is diffusely tender with guarding but no rebound tenderness. There is no cutaneous rash, urticaria, or wheezing. A CT scan of the abdomen with intravenous contrast demonstrates segmental small bowel wall thickening and free pelvic fluid, without evidence of bowel obstruction. Laboratory evaluation shows a normal complete blood count, a normal basic metabolic panel, and a significantly decreased serum C4 level.

Administration of an agent with which of the following mechanisms of action is most appropriate for the acute management of this patient's current symptoms?

Antagonism of bradykinin B2 receptors

Agonism of alpha-1, beta-1, and beta-2 adrenergic receptors

Inverse agonism of peripheral H1 histamine receptors

Inhibition of phospholipase A2 and reduction of inflammatory cytokine transcription

Inhibition of angiotensin-converting enzyme to reduce kinin degradation

Show answer & explanation

Answer: Antagonism of bradykinin B2 receptors

Answer

Antagonism of bradykinin B2 receptors

The correct answer is antagonism of bradykinin B2 receptors. This patient is presenting with a gastrointestinal attack of hereditary angioedema (HAE). HAE is an autosomal dominant immunologic disorder caused by a quantitative or functional deficiency of C1 esterase inhibitor (C1-INH). C1-INH normally inhibits the classical complement pathway and the kallikrein-kinin system. Its absence leads to unchecked activation of kallikrein, resulting in excessive production of bradykinin, the primary mediator of vascular permeability in this disease. The chronically uninhibited cleavage of C4 by C1 makes a low serum C4 level a reliable diagnostic marker. Acute attacks can cause life-threatening laryngeal edema or severe abdominal pain due to bowel wall edema, mimicking a surgical abdomen. Acute management requires targeting the specific pathophysiologic pathway, utilizing agents such as a bradykinin B2 receptor antagonist (icatibant), a kallikrein inhibitor (ecallantide), or purified C1-INH concentrate.

Step-by-Step Solution

Analyze the clinical presentation and history.

The patient has recurrent episodes of nonpruritic swelling, severe abdominal pain (explained by bowel wall edema on CT), and a positive family history, strongly suggesting hereditary angioedema (HAE) rather than an allergic reaction.

Differentiating bradykinin-mediated angioedema (no urticaria, GI involvement) from histamine-mediated angioedema (urticaria, wheezing) is critical for acute management.

Evaluate the laboratory findings.

The significantly decreased serum C4 level confirms classical complement pathway consumption.

Low C4 is the primary screening test for C1 esterase inhibitor (C1-INH) deficiency, the underlying cause of HAE.

Identify the underlying immunopathologic mechanism.

C1-INH deficiency leads to uninhibited activation of the kallikrein-kinin system, resulting in massive overproduction of bradykinin, which causes profound vasodilation and increased vascular permeability.

Understanding the precise inflammatory mediator dictates the choice of pharmacotherapy.

Select the appropriate pharmacologic intervention.

Acute management of HAE requires blocking the effects of bradykinin (e.g., icatibant, a bradykinin B2 receptor antagonist), inhibiting kallikrein (ecallantide), or replacing C1-INH.

Standard allergic treatments (epinephrine, antihistamines, corticosteroids) are ineffective for bradykinin-mediated edema.

Key Concept

Pathophysiology and targeted pharmacotherapy of Hereditary Angioedema (HAE).

Question 1646Question →

A 51-year-old woman undergoes a core needle biopsy of a 2-cm, irregular, firm mass in the upper outer quadrant of her left breast, which was detected on routine screening mammography. The histopathology report confirms a diagnosis of invasive breast carcinoma of no special type (invasive ductal carcinoma). The pathologist assigns a histologic grade using the Nottingham grading system to help guide prognosis and treatment. Which of the following specific histopathologic features are evaluated to calculate this patient's Nottingham grade? (Select exactly 3)

Select all that apply

Proportion of the tumor composed of distinct glandular tubules

Degree of variability in tumor cell nuclear size and shape

Number of mitotic figures observed per high-power field

Presence of tumor cells within peritumoral lymphatic or vascular channels

Percentage of tumor cells demonstrating nuclear positivity for hormone receptors

Show answer & explanation

Answer: Proportion of the tumor composed of distinct glandular tubules; Degree of variability in tumor cell nuclear size and shape; Number of mitotic figures observed per high-power field

Answer

The Nottingham histologic grading system evaluates the proportion of tubule formation, the degree of nuclear pleomorphism, and the mitotic rate.

The Nottingham grading system (also known as the modified Bloom-Richardson-Elston grade) is the standard method for grading invasive breast cancer. It combines three specific morphologic parameters: the percentage of the tumor that forms distinct tubules or glands (tubule formation), the degree of variation in nuclear size and shape (nuclear pleomorphism), and the rate of cell division (mitotic count). Each parameter is assigned a score from 1 to 3, and the scores are summed to determine the final tumor grade (I, II, or III). This grading strongly correlates with tumor aggressiveness and patient prognosis.

Step-by-Step Solution

Identify the clinical objective presented in the vignette.

The goal is to determine the specific components used to calculate the Nottingham histologic grade for invasive breast carcinoma.

Understanding the precise elements of synoptic pathology reporting is crucial for interpreting oncology results and staging.

Recall the parameters evaluated in the Nottingham (modified Bloom-Richardson-Elston) grading system.

The system scores three morphologic features from 1 to 3: tubule formation, nuclear pleomorphism, and mitotic activity.

These three features assess the tumor's differentiation and proliferation directly from the H&E stained biopsy slide.

Differentiate these morphologic grading parameters from other prognostic variables.

Exclude independent prognostic factors such as lymphovascular invasion and molecular biomarkers like hormone receptor expression.

While essential for comprehensive patient management, these excluded factors do not contribute to the numeric histologic grade.

Key Concept

Components of the Nottingham Histologic Grade in Breast Carcinoma

Question 1647Question →

A 38-year-old woman is evaluated in the clinic for a newly discovered, painless swelling in her anterior neck. She has no history of radiation exposure to the head or neck and no family history of endocrine malignancies. Physical examination reveals a 2.5-cm, firm, non-tender, mobile nodule in the right lobe of the thyroid gland. Her thyroid-stimulating hormone (TSH) level is within normal limits. A neck ultrasound shows a solid, hypoechoic nodule with irregular margins and microcalcifications. Fine-needle aspiration (FNA) of the nodule is performed. The cytopathology report describes highly cellular smears with flat sheets and syncytial clusters of epithelial cells. The cells demonstrate enlarged, overlapping nuclei with finely dispersed, optically clear chromatin, longitudinal nuclear grooves, and distinct intranuclear pseudoinclusions. Scattered concentrically laminated calcifications are also noted.

Based on the cytopathology findings, which of the following is the most likely diagnosis?

Papillary thyroid carcinoma

Follicular thyroid carcinoma

Medullary thyroid carcinoma

Hashimoto thyroiditis

Anaplastic thyroid carcinoma

Show answer & explanation

Answer: Papillary thyroid carcinoma

Answer

Papillary thyroid carcinoma

The correct diagnosis is papillary thyroid carcinoma. The cytopathology report details the pathognomonic microscopic features required to establish this diagnosis. These classic features include enlarged, overlapping nuclei with cleared, pale chromatin (often referred to as 'Orphan Annie eye' nuclei), prominent longitudinal nuclear grooves, and intranuclear pseudoinclusions (which are actually cytoplasmic invaginations into the nucleus). Furthermore, the 'concentrically laminated calcifications' represent psammoma bodies. Psammoma bodies are highly characteristic of papillary thyroid carcinoma and perfectly correlate with the microcalcifications observed on the patient's neck ultrasound.

Step-by-Step Solution

Analyze the patient's clinical presentation and ultrasound findings.

The patient has an asymptomatic, firm thyroid nodule with normal TSH. Ultrasound shows concerning features (solid, hypoechoic, microcalcifications), which correctly prompted a diagnostic fine-needle aspiration.

Establishing the clinical context and indication for the biopsy is the first step in evaluating a suspected thyroid malignancy.

Interpret the cytopathological features detailed in the fine-needle aspiration report.

The report highlights overlapping nuclei with optically clear chromatin ('Orphan Annie eyes'), longitudinal nuclear grooves, intranuclear pseudoinclusions, and concentrically laminated calcifications (psammoma bodies).

Accurate identification of specific microscopic cellular features is required to establish the correct pathologic diagnosis.

Correlate the cytopathology findings with the correct diagnosis.

The constellation of clear nuclei, nuclear grooves, pseudoinclusions, and psammoma bodies is highly specific and pathognomonic for papillary thyroid carcinoma.

Synthesizing the microscopic findings leads to the definitive diagnosis, distinguishing it from other malignant or benign thyroid conditions.

Key Concept

The cytopathological diagnosis of papillary thyroid carcinoma relies on distinct nuclear features, including optically clear chromatin ('Orphan Annie eyes'), nuclear grooves, intranuclear pseudoinclusions, and the presence of psammoma bodies.

Question 1648Question →

A 62-year-old man with a 35-pack-year smoking history schedules an appointment at a primary care office. He was recently informed that a baseline chest radiograph, required for a life insurance policy, revealed a 1.4-cm non-calcified opacity in the left upper lobe. He is completely asymptomatic and denies any history of malignancy, weight loss, or hemoptysis. His vital signs and physical examination are unremarkable. A comprehensive review of his electronic medical record reveals no prior chest imaging is available for comparison.

Assuming each successive investigation yields findings highly suspicious for a primary bronchogenic carcinoma, arrange the following imaging and image-guided diagnostic studies in the most appropriate chronological sequence for the comprehensive evaluation and systemic staging of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the diagnostic imaging and staging of a suspicious solitary pulmonary nodule is: 1) Thin-section CT of the chest without contrast, 2) Whole-body 18F-FDG PET scan, 3) Endobronchial ultrasound (EBUS) with guided needle aspiration, and 4) MRI of the brain with intravenous gadolinium.

The evaluation of a newly discovered solitary pulmonary nodule begins with a thin-section non-contrast CT of the chest to define its anatomic features. For a high-risk patient with a solid nodule larger than 8 mm, an 18F-FDG PET scan is sequentially ordered to evaluate metabolic activity and screen for extrathoracic disease. This is followed by an image-guided biopsy, such as EBUS-FNA, which provides both a tissue diagnosis and mediastinal lymph node staging. Finally, if lung cancer is confirmed, a contrast-enhanced MRI of the brain is ordered to complete the staging process by ruling out occult intracranial metastases prior to definitive treatment.

Step-by-Step Solution

Determine the initial characterization modality for a new pulmonary nodule found on radiography.

Thin-section CT of the chest without contrast is selected.

Chest radiography lacks the resolution to fully characterize a nodule. A non-contrast CT is required to evaluate the nodule's size, borders, attenuation, and calcification pattern, and to establish a precise baseline.

Select the appropriate imaging study to assess the risk of malignancy and regional spread for a high-risk solid nodule >8 mm.

Whole-body 18F-FDG PET scan is selected.

Once CT confirms a suspicious solid lesion >8 mm in a high-risk patient, a PET scan evaluates the metabolic avidity of the primary tumor and screens for occult regional and distant metastases, which guides the biopsy approach.

Identify the best modality for tissue diagnosis and mediastinal staging.

Endobronchial ultrasound (EBUS) with guided needle aspiration is selected.

Following a suspicious PET scan, an image-guided biopsy is necessary. EBUS-FNA is preferred as it allows for direct visualization and sampling of the primary lesion and systematic sampling of mediastinal lymph nodes for accurate N-staging.

Determine the necessary preoperative staging imaging for confirmed lung cancer.

MRI of the brain with intravenous gadolinium is selected.

If the biopsy confirms non-small cell lung cancer (NSCLC) and the patient is a candidate for curative resection, an MRI of the brain is required to exclude asymptomatic cerebral metastases, as the brain is a common site of spread not adequately evaluated by PET.

Key Concept

The diagnostic and staging sequence for a suspicious solitary pulmonary nodule >8 mm involves initial anatomic characterization with non-contrast CT, metabolic assessment with FDG-PET, definitive tissue diagnosis via image-guided biopsy (e.g., EBUS), and complete systemic staging including brain MRI if malignancy is confirmed.

Estimated Time:2m 0s

Question 1649Question →

A 45-year-old man is evaluated in the outpatient clinic for right hand clumsiness and numbness that has progressively worsened over the past four weeks. He recently began training for a long-distance cycling event and spends up to 15 hours a week riding his bicycle. He has no other medical conditions and takes no medications. Vital signs are within normal limits. On physical examination, there is decreased pinprick and light touch sensation over the palmar aspect of the right fifth digit and the medial half of the fourth digit. Sensation is completely intact over the dorsal aspect of the medial hand and the medial aspect of the forearm. Motor examination reveals weakness with adduction and abduction of the digits. Finger flexion strength is symmetric and normal bilaterally. Based on these physical examination findings, which of the following is the most likely anatomic site of this patient's nerve compression?

Groove between the medial epicondyle and the olecranon

Space deep to the transverse carpal ligament

Canal between the pisiform and the hook of the hamate

Spiral groove of the mid-shaft of the humerus

Triangle formed by the anterior and middle scalene muscles

Show answer & explanation

Answer: Canal between the pisiform and the hook of the hamate

Answer

Canal between the pisiform and the hook of the hamate (Guyon canal)

The correct answer is the canal between the pisiform and the hook of the hamate, clinically known as Guyon canal. This patient has physical examination findings consistent with an ulnar neuropathy (cyclist's palsy) localized precisely to the wrist. The ulnar nerve provides sensation to the palmar aspect of the fifth digit and medial half of the fourth digit, and motor innervation to the intrinsic hand muscles (interossei and lumbricals). Crucially, the physical examination reveals completely intact sensation over the dorsal medial hand and preserved finger flexion. The dorsal cutaneous branch of the ulnar nerve branches off from the main nerve in the distal forearm, approximately 5 cm proximal to the wrist, to supply the dorsal medial hand. Therefore, compression at the wrist (Guyon canal) will spare dorsal sensation, whereas compression at the elbow (cubital tunnel) will impair both palmar and dorsal sensation. Furthermore, motor branches to the flexor carpi ulnaris and the medial half of the flexor digitorum profundus originate in the proximal forearm; their functional sparing on physical exam further confirms a distal (wrist) rather than proximal (elbow) compression site.

Step-by-Step Solution

Identify the affected peripheral nerve based on the general sensory and motor deficits.

The sensory deficit on the palmar fifth and medial fourth digits, combined with weakness of finger adductors and abductors (interossei muscles), confirms an ulnar nerve injury.

The ulnar nerve provides the specific sensory distribution to the medial one and a half digits and motor innervation to the intrinsic hand muscles.

Localize the exact level of the nerve lesion using specific spared physical examination findings.

Sensation on the dorsal medial hand is intact, and finger flexion is preserved. This localizes the compression to the wrist rather than the elbow.

The dorsal cutaneous branch of the ulnar nerve arises proximal to the wrist. Sparing of this branch indicates the lesion must be distal to its takeoff.

Key Concept

Localization of ulnar nerve lesions using physical examination findings (differentiating Guyon canal from cubital tunnel compression).

Question 1650Question →

During a routine review of laboratory results at a skilled nursing facility, an attending physician is alerted to a resident exhibiting new-onset lethargy and generalized skeletal discomfort. Blood chemistry analysis demonstrates a serum calcium concentration of $14.8 \text{ mg/dL}$ , accompanied by a serum creatinine of $2.6 \text{ mg/dL}$ and a notably low serum anion gap of $4 \text{ mEq/L}$ . Subsequent endocrinology panels reveal a profoundly suppressed intact parathyroid hormone (PTH) level, an undetectable parathyroid hormone-related peptide (PTHrP), and low-normal levels of $1,25$ -dihydroxyvitamin D. Based on this specific pathophysiological profile, arrange the following differential diagnoses in descending order of their probability, from the most likely underlying etiology to the definitively excluded condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from most likely to least likely is: Multiple myeloma, followed by Osteolytic metastatic carcinoma, Humoral hypercalcemia of malignancy, and finally Primary hyperparathyroidism.

The correct sequence precisely stratifies the differential diagnoses based on pathophysiological mechanisms deduced from the laboratory profile. Multiple myeloma comprehensively accounts for all findings, including the specific low anion gap. Osteolytic metastases fit the endocrine profile but fail to explain the anion gap. Humoral hypercalcemia is heavily contradicted by the undetectable PTHrP level. Finally, primary hyperparathyroidism is completely incompatible with the profoundly suppressed intact PTH.

Step-by-Step Solution

Analyze the initial chemistry panel, specifically noting the severe hypercalcemia, renal impairment, and low anion gap.

Identified hypercalcemia (

14.8 \text{ mg/dL}

) requiring immediate mechanism differentiation, along with a low anion gap (

4 \text{ mEq/L}

) which strongly suggests the presence of unmeasured cationic proteins.

Establishing the severity of hypercalcemia and recognizing the low anion gap narrows the differential diagnosis early in the clinical reasoning process.

Evaluate the parathyroid hormone (PTH) axis.

The profoundly suppressed intact PTH level immediately definitively excludes primary and tertiary hyperparathyroidism.

Intact PTH is the primary branch point in the hypercalcemia diagnostic algorithm; suppression indicates a PTH-independent mechanism.

Assess the PTH-independent mechanisms using PTHrP and Vitamin D levels.

Undetectable PTHrP excludes humoral hypercalcemia of malignancy, and low-normal

1,25

-dihydroxyvitamin D excludes granulomatous disease. The remaining mechanism is local osteolytic hypercalcemia.

Systematic elimination of circulating hypercalcemic factors isolates the pathology to the local bone microenvironment.

Differentiate between the remaining local osteolytic causes based on secondary clinical clues.

Multiple myeloma explains both the local osteoclastic activation and the low anion gap (due to cationic IgG paraproteins). Osteolytic metastases explain the hypercalcemia but not the low anion gap.

Matching all clinical data points, including subtle clues like the anion gap, establishes the most precise pre-test probability ranking.

Key Concept

The diagnostic algorithm for hypercalcemia relies on stratifying PTH-dependent versus PTH-independent mechanisms, utilizing PTHrP and Vitamin D to isolate specific etiologies, while incorporating subtle chemistry findings (like a low anion gap) to pinpoint multiple myeloma.

Question 1651Question →

A 65-year-old man with a history of atrial fibrillation presents to the emergency department with acute onset right-sided hemiparesis and expressive aphasia. If magnetic resonance imaging (MRI) of the brain is obtained over the course of his illness, arrange the following characteristic imaging findings of an ischemic stroke in the correct chronological order of their typical initial appearance, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological order of appearance is: Restricted diffusion on DWI (minutes), followed by Hyperintensity on FLAIR (4-6 hours), then Cortical gyral enhancement (1-2 weeks), and finally Cystic encephalomalacia (months to years).

The correct sequence mirrors the pathophysiological evolution of a cerebral infarction. Cytotoxic edema occurs almost immediately after blood flow ceases, restricting water molecule movement and causing hyperintensity on DWI within minutes. As cell membranes fail and fluid leaks into the interstitial space over the next several hours (typically 4-6 hours), vasogenic edema develops, which is seen as hyperintensity on T2 and FLAIR sequences. By the end of the first week (subacute phase), breakdown of the blood-brain barrier occurs, leading to characteristic cortical gyral enhancement on post-contrast imaging. Finally, in the chronic phase (months to years), macrophages clear the necrotic debris, leaving behind cystic cavities (encephalomalacia) and resulting in compensatory local volume loss.

Step-by-Step Solution

Identify the underlying pathology being described in the clinical vignette.

The acute onset of focal neurologic deficits in a patient with atrial fibrillation describes an acute ischemic stroke, likely cardioembolic in origin.

Recognizing the pathology is necessary to understand the expected sequence of pathophysiologic cellular changes in the brain parenchyma.

Determine the imaging modality and sequence most sensitive to hyperacute cellular changes.

Restricted diffusion on DWI is placed first.

Cytotoxic edema causes immediate restriction of water molecule movement, making DWI positive within minutes of ischemia.

Identify the onset of macroscopic tissue edema.

Hyperintensity on FLAIR is placed second.

Vasogenic edema takes longer to develop, typically making the infarcted tissue hyperintense on FLAIR and T2-weighted sequences after 4 to 6 hours.

Determine the timing of blood-brain barrier disruption and chronic tissue resorption.

Cortical enhancement is placed third, and encephalomalacia is placed fourth.

Blood-brain barrier breakdown allows contrast extravasation in the subacute phase (1-2 weeks). Eventual clearing of necrotic tissue leads to chronic cystic cavities and volume loss (months to years).

Key Concept

The temporal evolution of ischemic stroke on MRI proceeds sequentially from early cytotoxic edema (DWI), to vasogenic edema (FLAIR), to subacute blood-brain barrier breakdown (contrast enhancement), and finally to chronic tissue cavitation (encephalomalacia).

Question 1652Question →

A $34$ -year-old woman is referred to the endocrinology clinic due to unexplained weight gain of $15$ kg over the past year, accompanied by easy bruising and new-onset facial hair growth. She reports that her menstrual periods, previously regular, now occur only once every $3$ to $4$ months. Vital signs show a blood pressure of $158/98$ mm Hg. Physical examination is notable for facial plethora, a dorsocervical fat pad, truncal obesity with thin extremities, and wide, purplish striae over the lower abdomen and flanks. The physician suspects hypercortisolism. Assuming the patient ultimately has a pituitary adenoma (Cushing disease) and each successive diagnostic test dictates the need for further localization, arrange the following laboratory tests and diagnostic procedures in the correct sequential order from initial screening to definitive confirmation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is:

24

-hour urine free cortisol measurement, followed by Plasma ACTH assay, then High-dose (

8

-mg) dexamethasone suppression test, and finally Inferior petrosal sinus sampling (IPSS).

The diagnosis of Cushing syndrome follows a strict sequential algorithm to minimize false positives and avoid unnecessary invasive testing. First, endogenous hypercortisolism must be confirmed with a primary screening test, such as the

24

-hour urine free cortisol measurement, late-night salivary cortisol, or a low-dose dexamethasone suppression test. Once hypercortisolism is established, the second step is measuring plasma ACTH to differentiate ACTH-independent (adrenal) from ACTH-dependent (pituitary/ectopic) causes. Third, if the condition is ACTH-dependent, a high-dose (

8

-mg) dexamethasone suppression test is used to distinguish a pituitary adenoma (which usually suppresses) from an ectopic ACTH-secreting tumor (which typically does not suppress). Finally, if non-invasive tests and imaging are equivocal, inferior petrosal sinus sampling (IPSS) is performed to definitively confirm a central pituitary source of ACTH.

Step-by-Step Solution

Confirm the presence of hypercortisolism.

Order a

24

-hour urine free cortisol measurement.

To avoid unnecessary downstream localization testing, biochemical confirmation of endogenous hypercortisolism using a first-line screening test is the mandatory first step.

Determine ACTH dependence.

Order a plasma ACTH assay.

Once hypercortisolism is confirmed, measuring ACTH differentiates between ACTH-independent (adrenal tumors) and ACTH-dependent (pituitary or ectopic) sources.

Differentiate ACTH-dependent sources.

Order a high-dose (

8

-mg) dexamethasone suppression test.

Pituitary adenomas typically retain some negative feedback and will suppress cortisol production at high dexamethasone doses, whereas ectopic ACTH-producing tumors typically do not suppress.

Confirm pituitary lateralization and source invasively.

Order inferior petrosal sinus sampling (IPSS).

If non-invasive biochemical tests are equivocal or discordant with pituitary magnetic resonance imaging, IPSS directly measures the central-to-peripheral ACTH gradient to definitively confirm Cushing disease.

Key Concept

The sequential diagnostic evaluation of Cushing syndrome begins with confirming hypercortisolism, followed by determining ACTH dependence, differentiating the ACTH source using high-dose suppression testing, and ultimately using invasive sampling if non-invasive localization is equivocal.

Estimated Time:1m 30s

Question 1653Question →

A 58-year-old man presents to the emergency department with profound weakness and an inability to stand. He has a 40-pack-year smoking history. Over the past three months, he has experienced a $12\text{ kg}$ ( $26\text{ lb}$ ) weight loss and noticed darkening of his skin creases. Two weeks ago, his primary care physician started him on lisinopril and hydrochlorothiazide for new-onset hypertension. His blood pressure is $165/95\text{ mm Hg}$ . Physical examination reveals temporal wasting, proximal muscle weakness, and hyperpigmentation of the palmar creases.

Laboratory studies show:
Sodium: $144\text{ mEq/L}$
Potassium: $2.1\text{ mEq/L}$
Chloride: $98\text{ mEq/L}$
Bicarbonate: $35\text{ mEq/L}$
Morning serum cortisol: $92\text{ }\mu\text{g/dL}$ (Reference: $5-23\text{ }\mu\text{g/dL}$ )
Plasma ACTH: $480\text{ pg/mL}$ (Reference: $10-60\text{ pg/mL}$ )

Based on the clinical presentation and laboratory findings, which of the following is the primary cellular mechanism responsible for this patient's profound hypokalemia?

Direct paraneoplastic secretion of aldosterone by the suspected malignancy

Excessive adrenocorticotropic hormone stimulation of the adrenal zona glomerulosa

Saturation of the renal enzyme 11-\beta-hydroxysteroid dehydrogenase type 2

Severe secondary hyperaldosteronism caused by the thiazide diuretic therapy

Lisinopril-induced exacerbation of distal tubular potassium wasting

Show answer & explanation

Answer: Saturation of the renal enzyme 11-\beta-hydroxysteroid dehydrogenase type 2

Answer

Saturation of the renal enzyme 11-\beta-hydroxysteroid dehydrogenase type 2

The correct mechanism is the saturation of the renal enzyme 11-beta-hydroxysteroid dehydrogenase type 2. This patient's presentation (weight loss, smoking history, hyperpigmentation, severe hypercortisolism, and markedly elevated ACTH) is classic for ectopic ACTH syndrome, most commonly due to small cell lung cancer. Cortisol binds to the mineralocorticoid receptor with the same affinity as aldosterone. Under normal conditions, the kidneys are protected from this mineralocorticoid effect by the enzyme 11-beta-hydroxysteroid dehydrogenase type 2, which converts active cortisol into inactive cortisone. However, in states of massive cortisol excess like ectopic ACTH syndrome, this enzyme is overwhelmed and saturated. The excess unmetabolized cortisol binds to mineralocorticoid receptors in the renal collecting duct, leading to unregulated sodium reabsorption and severe distal tubular potassium and hydrogen ion excretion.

Step-by-Step Solution

Analyze the clinical presentation and lab values.

The patient has severe hypokalemia, metabolic alkalosis, weight loss, hyperpigmentation, high cortisol, and very high ACTH.

Identifying the primary syndrome is necessary before determining the cellular mechanism of the electrolyte derangement.

Formulate a diagnosis based on the combined findings.

The combination of heavy smoking, weight loss, very high ACTH, and hypercortisolism strongly points to ectopic ACTH syndrome (likely secondary to small cell lung cancer).

Ectopic ACTH production explains the hyperpigmentation (co-secretion of MSH with ACTH) and massive hypercortisolism.

Connect the diagnosis to the specific electrolyte abnormality.

Identify how massive hypercortisolism causes mineralocorticoid excess effects (hypokalemia and metabolic alkalosis).

The question specifically asks for the cellular mechanism driving the profound hypokalemia.

Determine the biochemical mechanism of apparent mineralocorticoid excess in Cushing syndrome.

Cortisol binds with equal affinity to the mineralocorticoid receptor as aldosterone. Normally, 11-beta-HSD2 converts cortisol to inactive cortisone in the kidney. In ectopic ACTH, the massive amount of cortisol saturates this enzyme.

When 11-beta-HSD2 is saturated, excess active cortisol acts on the mineralocorticoid receptors in the distal tubule, causing sodium reabsorption and severe potassium wasting.

Key Concept

In conditions with massive hypercortisolism (such as ectopic ACTH syndrome), the renal enzyme 11-beta-hydroxysteroid dehydrogenase type 2 becomes saturated. This allows high levels of circulating cortisol to cross-react with and activate the mineralocorticoid receptor, resulting in severe hypokalemia, metabolic alkalosis, and hypertension.

Question 1654Question →

A 68-year-old man is admitted to the intensive care unit with an acute exacerbation of heart failure. On hospital day 3, he experiences sudden-onset right-sided pleuritic chest pain and worsening dyspnea. His temperature is 37.1°C (98.8°F), blood pressure is 115/75 mm Hg, pulse is 118/min, and respiratory rate is 24/min. Oxygen saturation is 88% on 4 L/min via nasal cannula, decreased from 95% on 2 L/min yesterday. Physical examination reveals elevated jugular venous pressure, bilateral basilar crackles, and bilateral 2+ pitting edema extending to the knees. The right calf appears slightly more swollen than the left.

Laboratory studies:
Serum creatinine: 3.4 mg/dL (baseline 1.2 mg/dL)
Brain natriuretic peptide: 1,800 pg/mL

ECG shows sinus tachycardia and new T-wave inversions in leads V1-V4. A portable chest radiograph reveals bilateral pleural effusions and prominent interstitial markings consistent with pulmonary edema. The clinical team suspects an acute pulmonary embolism. Which of the following is the most appropriate next imaging study to evaluate for suspected pulmonary embolism in this patient?

Computed tomography pulmonary angiography

Ventilation-perfusion (V/Q) scanning

Transthoracic echocardiography

Magnetic resonance angiography of the chest

Lower extremity compression ultrasonography

Show answer & explanation

Answer: Lower extremity compression ultrasonography

Answer

Lower extremity compression ultrasonography is the most appropriate next step.

The correct answer identifies the optimal alternative diagnostic strategy when standard PE imaging pathways are blocked. CT pulmonary angiography is contraindicated due to the patient's severe acute kidney injury. The primary alternative, a ventilation-perfusion (V/Q) scan, is heavily compromised by the patient's severe pulmonary edema and bilateral pleural effusions, which would likely result in an indeterminate reading. In patients with a high pretest probability for PE who cannot undergo definitive chest imaging, lower extremity compression ultrasonography is the preferred next step. Finding a deep vein thrombosis (especially given the asymmetric calf swelling) confirms the presence of venous thromboembolism and dictates the same management as a PE (therapeutic anticoagulation), eliminating the immediate need for potentially harmful or inconclusive chest imaging.

Step-by-Step Solution

Assess the pretest probability of pulmonary embolism (PE) and identify the standard diagnostic imaging.

The patient has a high clinical suspicion for an acute PE based on symptoms, tachycardia, and hypoxia. Computed tomography pulmonary angiography (CTPA) is typically the initial diagnostic test of choice.

CTPA provides rapid and definitive visualization of the pulmonary vasculature.

Evaluate for contraindications to the standard imaging modality.

The patient has developed severe acute kidney injury (creatinine 3.4 mg/dL), which serves as a major contraindication to the iodinated contrast required for CTPA.

Administering iodinated contrast in this setting poses a high risk of exacerbating the acute kidney injury.

Determine the viability of standard alternative chest imaging modalities.

A ventilation-perfusion (V/Q) scan is typically the next best alternative; however, it is likely to be non-diagnostic in this patient due to the concurrent pulmonary edema and pleural effusions noted on the chest radiograph.

An abnormal chest radiograph significantly reduces the diagnostic accuracy of a V/Q scan because alveolar filling and pleural fluid obscure the typical mismatched perfusion defects.

Select the safest, most effective alternative diagnostic pathway.

Lower extremity compression ultrasonography should be performed next.

Diagnosing a deep vein thrombosis (DVT) confirms venous thromboembolism. Because the treatment (therapeutic anticoagulation) is the same for DVT and PE, a positive ultrasound provides actionable data without exposing the patient to contrast or radiation, and circumvents the limitations of a V/Q scan.

Key Concept

Diagnostic approach to suspected pulmonary embolism when standard imaging is contraindicated.

Question 1655Question →

For each patient presenting with hepatobiliary or systemic symptoms, select the most appropriate diagnostic laboratory test to confirm the underlying etiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Primary Biliary Cholangitis requires an Antimitochondrial antibody assay; Autoimmune Hepatitis requires Anti-smooth muscle and antinuclear antibodies; Hereditary Hemochromatosis requires Fasting transferrin saturation and serum ferritin; and Wilson disease requires a Serum ceruloplasmin level.

Each laboratory test serves as a highly specific diagnostic marker for a distinct etiology of hepatobiliary disease. AMA confirms Primary Biliary Cholangitis. Fasting iron studies (transferrin saturation and ferritin) screen for Hereditary Hemochromatosis. Serum ceruloplasmin is the necessary initial step for Wilson disease. ASMA and ANA are required for diagnosing Autoimmune Hepatitis.

Step-by-Step Solution

Analyze the patient demographics and symptom profile.

Categorize the presentation into distinct clinical syndromes: isolated cholestasis (pruritus, high alk phos), acute hepatocellular injury (jaundice, high AST/ALT), iron overload (bronze skin, diabetes, hypogonadism), and copper accumulation (neuropsychiatric signs, early-onset liver disease).

Different etiologies of liver and systemic diseases present with characteristic symptom clusters and biochemical patterns.

Select the confirmatory serologic or biochemical test for each suspected condition.

Match PBC with AMA, AIH with ASMA/ANA, Hemochromatosis with iron studies, and Wilson disease with ceruloplasmin.

Targeted diagnostic testing minimizes unnecessary investigations and definitively establishes the diagnosis for these autoimmune and metabolic conditions.

Key Concept

Selecting specific diagnostic laboratory tests based on distinct clinical and biochemical patterns of liver disease.

Question 1656Question →

A $64$ -year-old man comes to the clinic for a follow-up visit regarding progressive shortness of breath and a persistent cough for the past $6$ months. He has a $15$ -year history of severe, deforming rheumatoid arthritis for which he takes methotrexate and low-dose prednisone. He has a $30$ -pack-year smoking history. Temperature is $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), blood pressure is $135/85\text{ mm Hg}$ , pulse is $88/\text{min}$ , and respirations are $20/\text{min}$ . Physical examination reveals decreased breath sounds and dullness to percussion over the right lower lung field. Joint examination shows ulnar deviation and swan-neck deformities of the fingers.

A chest radiograph demonstrates a moderate-sized right-sided pleural effusion. Thoracentesis yields a milky, opaque fluid.

Pleural fluid analysis and concurrent serum laboratory studies show the following:

Serum:
Total protein: $6.8\text{ g/dL}$
Lactate dehydrogenase (LDH): $190\text{ U/L}$

Pleural fluid:
Appearance: Milky, opaque
Cell count: $2,800/\text{mm}^3$ ( $85\%$ lymphocytes, $15\%$ neutrophils)
Total protein: $4.8\text{ g/dL}$
Lactate dehydrogenase (LDH): $410\text{ U/L}$
Glucose: $22\text{ mg/dL}$
Triglycerides: $35\text{ mg/dL}$
Cholesterol: $260\text{ mg/dL}$
Gram stain: No organisms

Which of the following best describes the pathogenesis of this patient's pleural fluid findings?

Accumulation of cholesterol from degenerating cells in a chronic effusion

Leakage of chylomicrons into the pleural space due to thoracic duct disruption

Accumulation of polymorphonuclear leukocytes and cellular debris from bacterial infection

Fluid migration across diaphragmatic defects driven by a positive pressure gradient

Ultrafiltration of plasma secondary to elevated pulmonary capillary wedge pressure

Show answer & explanation

Answer: Accumulation of cholesterol from degenerating cells in a chronic effusion

Answer

The pathogenesis is the accumulation of cholesterol from degenerating cells in a chronic effusion, which is diagnostic of a pseudochylothorax (chyliform effusion).

The correct answer describes the pathogenesis of a pseudochylothorax (chyliform effusion). This patient's milky pleural fluid is an exudate (by Light's criteria) with low triglycerides (

35\text{ mg/dL}

) and elevated cholesterol (

260\text{ mg/dL}

). This specific lipid profile differentiates it from a chylothorax (which would present with triglycerides

> 110\text{ mg/dL}

). Pseudochylothoraces typically develop in long-standing, chronic pleural effusions—most classically associated with rheumatoid arthritis or tuberculosis. Over months to years, erythrocytes and neutrophils in the enclosed pleural space degenerate, releasing their cellular membrane cholesterol, which crystallizes and gives the fluid its milky appearance. The markedly low pleural glucose (

22\text{ mg/dL}

) is another hallmark of rheumatoid pleurisy.

Step-by-Step Solution

Calculate Light's criteria using the provided pleural and serum total protein and LDH values.

The pleural-to-serum protein ratio is

4.8/6.8 = 0.71

(exceeds

0.5

) and the LDH ratio is

410/190 = 2.16

(exceeds

0.6

), indicating a highly exudative effusion.

Light's criteria serve as the mandatory first step to differentiate an exudate (local pleural disease) from a transudate (systemic fluid balance issue).

Interpret the specific lipid panel in the context of a milky, opaque pleural effusion.

The fluid has low triglycerides (

35\text{ mg/dL}

) and elevated cholesterol (

260\text{ mg/dL}

), firmly diagnosing a pseudochylothorax rather than a chylothorax.

Milky effusions can be caused by chyle (high triglycerides) or chronic cellular breakdown products (high cholesterol). The lipid profile is the only definitive way to differentiate them.

Synthesize the laboratory findings with the patient's clinical history.

The combination of a chronic exudate, severely depressed glucose (

22\text{ mg/dL}

), lymphocytic predominance, and high cholesterol establishes a diagnosis of rheumatoid pseudochylothorax.

Rheumatoid pleurisy classically presents with very low glucose levels and can evolve into a cholesterol-rich pseudochylothorax over time due to chronic, walled-off inflammation.

Key Concept

Pseudochylothorax is a chronic exudative pleural effusion characterized by a milky appearance, low triglycerides (

< 50\text{ mg/dL}

), and high cholesterol (

> 200\text{ mg/dL}

) resulting from the gradual breakdown of cellular debris.

Question 1657Question →

A physician is evaluating five patients who present with complex acid-base and electrolyte abnormalities. Match each patient's clinical and laboratory profile to the most likely underlying diagnosis. All serum electrolytes are reported in mEq/L. The reference range for serum anion gap is $8-12$ mEq/L.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Patient A matches with Distal (Type 1) RTA, Patient B with Hyporeninemic hypoaldosteronism, Patient C with Surreptitious vomiting, Patient D with Surreptitious loop diuretic abuse, and Patient E with Primary hyperaldosteronism.

Each patient requires a systemic approach to acid-base interpretation. Matching correctly relies on integrating multiple parameters: differentiating RTA types by potassium and urine pH, and evaluating metabolic alkalosis using urine chloride and blood pressure.

Step-by-Step Solution

Calculate the serum anion gap for acidotic patients

Patients A and B have a normal serum anion gap (

12

mEq/L), confirming hyperchloremic metabolic acidosis.

To classify the metabolic acidosis and determine if it is due to unmeasured anions or bicarbonate loss.

Evaluate potassium, urine anion gap, and urine pH in normal anion gap acidosis

Patient A has hypokalemia and urine pH

> 5.5

, indicating Type

1

RTA. Patient B has hyperkalemia and urine pH

< 5.5

, indicating Type

4

RTA.

To differentiate between renal tubular acidosis subtypes.

Analyze urine chloride in patients with metabolic alkalosis

Patient C has low urine Cl

^-

(

< 20

mEq/L), indicating saline-responsive alkalosis. Patients D and E have high urine Cl

^-

(

> 20

mEq/L), indicating saline-resistant alkalosis.

To determine volume status and chloride responsiveness.

Assess blood pressure in saline-resistant metabolic alkalosis

Patient D is normotensive, pointing to diuretic abuse. Patient E is hypertensive, pointing to primary hyperaldosteronism.

To distinguish between mineralocorticoid excess and renal salt-wasting states.

Key Concept

Interpretation of complex acid-base disorders requires algorithmic evaluation of the serum anion gap, potassium, urine pH, urine anion gap, urine chloride, and blood pressure to isolate the precise pathophysiological mechanism.

Question 1658Question →

An asymptomatic 72-year-old man presents to his primary care physician for a scheduled health maintenance visit. His past medical history is significant for polycythemia vera and essential hypertension. His daily medication regimen consists of low-dose aspirin and amlodipine. The patient states he feels completely well and denies any recent muscle weakness, palpitations, syncope, or shortness of breath.

Vital signs show a temperature of 37.0°C (98.6°F), blood pressure of 135/82 mmHg, pulse of 78/min, and respiratory rate of 14/min. Physical examination reveals a plethoric appearance of the face and mild splenomegaly. A 12-lead electrocardiogram demonstrates normal sinus rhythm with normal QRS duration and no ST-segment or T-wave abnormalities.

Laboratory results obtained from a serum sample are as follows:

Test	Result	Reference Range
Sodium	140 mEq/L	136–145 mEq/L
Potassium	6.7 mEq/L	3.5–5.0 mEq/L
Chloride	104 mEq/L	98–106 mEq/L
Bicarbonate	25 mEq/L	22–28 mEq/L
Blood urea nitrogen	16 mg/dL	8–20 mg/dL
Creatinine	1.0 mg/dL	0.6–1.2 mg/dL
Hemoglobin	17.5 g/dL	13.5–17.5 g/dL
Leukocytes	14,000/mm³	4,500–11,000/mm³
Platelets	1,250,000/mm³	150,000–400,000/mm³

Which of the following is the most likely mechanism responsible for the abnormal potassium level reported in this patient?

Release of intracellular potassium during in vitro blood clotting

Shift of potassium from the intracellular to the extracellular space

In vivo destruction of erythrocytes due to microvascular shear stress

Medication-induced impairment of the renin-angiotensin-aldosterone system

Decreased renal tubular secretion due to occult nephropathy

Show answer & explanation

Answer: Release of intracellular potassium during in vitro blood clotting

Answer

Release of intracellular potassium during in vitro blood clotting

The correct answer identifies the release of intracellular potassium during in vitro blood clotting as the cause of this patient's lab abnormality. This patient presents with an elevated serum potassium level of 6.7 mEq/L, but is completely asymptomatic and has a normal electrocardiogram (no peaked T waves, normal QRS duration). Crucially, the patient has a markedly elevated platelet count (1,250,000/mm³). Pseudohyperkalemia is an in vitro phenomenon where potassium is released from cells (platelets, leukocytes, or erythrocytes) during the clotting process in the collection tube. It is most frequently seen in patients with severe thrombocytosis or leukocytosis. Because the potassium is only elevated in the specimen tube and not in the patient's circulating plasma, the condition is benign and requires no treatment. The diagnosis can be confirmed by measuring potassium in a heparinized tube (plasma potassium), which prevents clotting and will reflect the true physiological level.

Step-by-Step Solution

Evaluate the patient's clinical presentation and electrocardiogram (ECG) findings in relation to the laboratory abnormality.

The patient is completely asymptomatic, and the ECG shows no classic signs of hyperkalemia (such as peaked T waves or widened QRS complexes) despite a severely elevated reported potassium of 6.7 mEq/L.

To determine whether the hyperkalemia represents a life-threatening, true physiologic state or a laboratory artifact.

Analyze the complete laboratory panel for underlying causes of the abnormal potassium value.

Renal function (BUN and creatinine) is normal, ruling out renal failure. Bicarbonate is normal, ruling out severe acidosis. However, the platelet count is massively elevated at 1,250,000/mm³ due to his myeloproliferative disorder.

To identify specific derangements that either explain true hyperkalemia or point toward a spurious result.

Synthesize the clinical and laboratory data to conclude the mechanism.

The extreme thrombocytosis leads to the massive release of intracellular potassium as platelets degranulate during the clotting process in the serum collection tube, causing pseudohyperkalemia.

To establish the diagnosis of pseudohyperkalemia, avoiding unnecessary and potentially harmful therapies like intravenous calcium or insulin.

Key Concept

Pseudohyperkalemia is a laboratory artifact typically caused by the in vitro release of intracellular potassium from cells (most commonly due to extreme thrombocytosis or leukocytosis) during specimen clotting.

Question 1659Question →

During bedside cardiovascular evaluation, several classic physical examination findings provide direct insight into underlying cardiopulmonary hemodynamics. Match the following peripheral pulse abnormalities or central venous pressure findings with their precise underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Pulsus paradoxus matches with exaggerated interventricular dependence; Kussmaul sign matches with impaired right-sided cardiac compliance; Pulsus bisferiens matches with rapid initial ejection followed by a second systolic wave; and Pulsus alternans matches with beat-to-beat variation in stroke volume due to fluctuating contractility.

Each physical examination maneuver or finding evaluates a distinct hemodynamic variable. Matching these clinical signs with their corresponding mechanical and physiologic derangements ensures accurate bedside diagnosis and directs appropriate subsequent imaging or therapy.

Step-by-Step Solution

Analyze 'Pulsus paradoxus'.

It describes a drop in systolic blood pressure greater than 10 mmHg during inspiration.

This physical finding directly reflects exaggerated ventricular interdependence, typically seen in cardiac tamponade.

Analyze 'Kussmaul sign'.

It is a paradoxical increase (or lack of decrease) in jugular venous pressure on inspiration.

This points to a rigid, non-compliant right ventricle (e.g., constrictive pericarditis) that cannot expand to accommodate increased inspiratory venous return.

Analyze 'Pulsus bisferiens'.

It is a pulse with two palpable systolic peaks.

This occurs in conditions with rapid left ventricular ejection such as severe aortic regurgitation, leading to an initial percussion wave followed by a tidal wave.

Analyze 'Pulsus alternans'.

It manifests as alternating strong and weak pulse amplitudes despite a regular heart rhythm.

This is a classic physical exam finding of profound left ventricular systolic failure, representing beat-to-beat alterations in myocardial contractility.

Key Concept

Cardiovascular physical examination signs and their underlying hemodynamic pathophysiology.

Question 1660Question →

A 47-year-old man presents to the primary care clinic complaining of progressive fatigue, decreased libido, and joint pain for the past 8 months. The joint pain primarily affects his hands. He has no significant past medical history and takes no medications. He drinks one or two beers on weekends and does not use tobacco or illicit drugs. Vital signs are within normal limits. Physical examination reveals a bronze hue to his skin, primarily on sun-exposed areas, and mild hepatomegaly. There is bony enlargement and tenderness over the second and third metacarpophalangeal joints bilaterally. Initial laboratory tests show:

Laboratory Test	Result	Reference Range
AST	58 U/L	10 - 40 U/L
ALT	64 U/L	10 - 40 U/L
Fasting blood glucose	118 mg/dL	70 - 99 mg/dL

Which of the following is the most appropriate next step in laboratory evaluation?

Serum transferrin saturation and ferritin

HFE gene mutation analysis

Antinuclear antibody and cyclic citrullinated peptide antibodies

Hepatitis B surface antigen and hepatitis C antibody

Early morning total serum testosterone

Show answer & explanation

Answer: Serum transferrin saturation and ferritin

Answer

Serum transferrin saturation and ferritin

The patient's clinical presentation—fatigue, bronze skin hyperpigmentation, decreased libido (secondary to iron deposition in the pituitary), hepatomegaly with mild transaminitis, and characteristic arthropathy of the second and third metacarpophalangeal (MCP) joints—is the classic presentation of hereditary hemochromatosis. The most appropriate initial laboratory step is to demonstrate phenotypic iron overload. This is accomplished by measuring serum transferrin saturation and serum ferritin levels. A transferrin saturation >45% is highly sensitive for the disease. Only after iron overload is biochemically confirmed should the physician proceed to confirmatory genetic testing.

Step-by-Step Solution

Analyze the clinical presentation for a unifying diagnosis.

The combination of fatigue, hepatomegaly, bronze skin, specific arthropathy (2nd/3rd MCP joints), and hypogonadism (decreased libido) points strongly to hereditary hemochromatosis.

Recognizing pattern presentation prevents premature closure on isolated symptoms like joint pain or mild transaminitis.

Identify the standard diagnostic pathway for the suspected condition.

The initial diagnostic step for hereditary hemochromatosis is demonstrating phenotypic iron overload.

Guidelines recommend biochemical screening prior to targeted genetic testing.

Select the appropriate laboratory test to execute the screening step.

Serum transferrin saturation and ferritin levels are ordered.

A transferrin saturation >45% with an elevated ferritin level warrants subsequent confirmatory HFE gene mutation analysis.

Key Concept

The initial laboratory evaluation for patients with suspected hereditary hemochromatosis is biochemical screening with serum transferrin saturation and ferritin levels, followed by confirmatory HFE gene mutation analysis if iron overload is present.

Estimated Time:1m 30s

PreviousPage 83 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept